NEWBUY

Buying a big cap today.Our first in the portfolio.This company wants to become a gene editing giant and we are going to bet on their success.They are buying Avity and recently had one great FDA news on their gene therapy work Trading at 15 times earnings this Swiss drug company could be a big winner.